Immunological parameters as a new lead in the diagnosis of ovarian cancer

Ovarian cancer is the leading cause of pelvic gynecological cancer death in Europe. Prognosis is poor in women diagnosed at stage III to IV or in case disease recurs. Platin-based chemotherapy and radical surgery have already improved prognosis significantly. Novel strategies in the treatment of ova...

Descripción completa

Detalles Bibliográficos
Autores principales: Baert, T., Timmerman, D., Vergote, I., Coosemans, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Universa Press 2015
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402445/
https://www.ncbi.nlm.nih.gov/pubmed/25897373
_version_ 1782367253370503168
author Baert, T.
Timmerman, D.
Vergote, I.
Coosemans, A.
author_facet Baert, T.
Timmerman, D.
Vergote, I.
Coosemans, A.
author_sort Baert, T.
collection PubMed
description Ovarian cancer is the leading cause of pelvic gynecological cancer death in Europe. Prognosis is poor in women diagnosed at stage III to IV or in case disease recurs. Platin-based chemotherapy and radical surgery have already improved prognosis significantly. Novel strategies in the treatment of ovarian cancer are being searched for. The study of the immune system as a valuable parameter in the development of ovarian cancer has been neglected for a long time. Nevertheless, this is a field in full progression and might open new perspectives in the diagnosis and prognosis of ovarian cancer patients and could lead to a more motivated choice of targeted therapies.
format Online
Article
Text
id pubmed-4402445
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Universa Press
record_format MEDLINE/PubMed
spelling pubmed-44024452015-04-20 Immunological parameters as a new lead in the diagnosis of ovarian cancer Baert, T. Timmerman, D. Vergote, I. Coosemans, A. Facts Views Vis Obgyn Viewpoint Ovarian cancer is the leading cause of pelvic gynecological cancer death in Europe. Prognosis is poor in women diagnosed at stage III to IV or in case disease recurs. Platin-based chemotherapy and radical surgery have already improved prognosis significantly. Novel strategies in the treatment of ovarian cancer are being searched for. The study of the immune system as a valuable parameter in the development of ovarian cancer has been neglected for a long time. Nevertheless, this is a field in full progression and might open new perspectives in the diagnosis and prognosis of ovarian cancer patients and could lead to a more motivated choice of targeted therapies. Universa Press 2015 /pmc/articles/PMC4402445/ /pubmed/25897373 Text en Copyright: © 2015 Facts, Views & Vision http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Viewpoint
Baert, T.
Timmerman, D.
Vergote, I.
Coosemans, A.
Immunological parameters as a new lead in the diagnosis of ovarian cancer
title Immunological parameters as a new lead in the diagnosis of ovarian cancer
title_full Immunological parameters as a new lead in the diagnosis of ovarian cancer
title_fullStr Immunological parameters as a new lead in the diagnosis of ovarian cancer
title_full_unstemmed Immunological parameters as a new lead in the diagnosis of ovarian cancer
title_short Immunological parameters as a new lead in the diagnosis of ovarian cancer
title_sort immunological parameters as a new lead in the diagnosis of ovarian cancer
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402445/
https://www.ncbi.nlm.nih.gov/pubmed/25897373
work_keys_str_mv AT baertt immunologicalparametersasanewleadinthediagnosisofovariancancer
AT timmermand immunologicalparametersasanewleadinthediagnosisofovariancancer
AT vergotei immunologicalparametersasanewleadinthediagnosisofovariancancer
AT coosemansa immunologicalparametersasanewleadinthediagnosisofovariancancer

Ejemplares similares